全文获取类型
收费全文 | 10338篇 |
免费 | 604篇 |
国内免费 | 115篇 |
专业分类
耳鼻咽喉 | 150篇 |
儿科学 | 230篇 |
妇产科学 | 139篇 |
基础医学 | 1671篇 |
口腔科学 | 189篇 |
临床医学 | 909篇 |
内科学 | 2059篇 |
皮肤病学 | 533篇 |
神经病学 | 876篇 |
特种医学 | 549篇 |
外科学 | 1188篇 |
综合类 | 23篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 525篇 |
眼科学 | 203篇 |
药学 | 1027篇 |
中国医学 | 146篇 |
肿瘤学 | 638篇 |
出版年
2024年 | 12篇 |
2023年 | 88篇 |
2022年 | 263篇 |
2021年 | 389篇 |
2020年 | 223篇 |
2019年 | 272篇 |
2018年 | 342篇 |
2017年 | 276篇 |
2016年 | 373篇 |
2015年 | 448篇 |
2014年 | 584篇 |
2013年 | 598篇 |
2012年 | 923篇 |
2011年 | 936篇 |
2010年 | 496篇 |
2009年 | 462篇 |
2008年 | 632篇 |
2007年 | 578篇 |
2006年 | 473篇 |
2005年 | 484篇 |
2004年 | 379篇 |
2003年 | 328篇 |
2002年 | 319篇 |
2001年 | 192篇 |
2000年 | 192篇 |
1999年 | 139篇 |
1998年 | 65篇 |
1997年 | 37篇 |
1996年 | 42篇 |
1995年 | 24篇 |
1994年 | 40篇 |
1993年 | 26篇 |
1992年 | 46篇 |
1991年 | 49篇 |
1990年 | 40篇 |
1989年 | 53篇 |
1988年 | 29篇 |
1987年 | 31篇 |
1986年 | 29篇 |
1985年 | 25篇 |
1984年 | 14篇 |
1983年 | 8篇 |
1982年 | 6篇 |
1981年 | 10篇 |
1980年 | 15篇 |
1979年 | 16篇 |
1978年 | 7篇 |
1977年 | 10篇 |
1970年 | 4篇 |
1967年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 25 毫秒
1.
Neurofibromatosis Type 1 Diagnosed in a Child Based on Multiple Juvenile Xanthogranulomas and Juvenile Myelomonocytic Leukemia
下载免费PDF全文
![点击此处可从《Pediatric dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Sune R. R. Jans M.D. Eckhard Schomerus M.D. Anette Bygum M.D. 《Pediatric dermatology》2015,32(1):e29-e32
An association between juvenile xanthogranuloma (JXG), neurofibromatosis type 1 (NF1), and juvenile myelomonocytic leukemia (JMML) has been described in the literature but has only been documented in approximately 20 cases. We diagnosed a patient with NF1 at 25 months of age, before any cutaneous stigmata of this disease had appeared, because we decided to screen for the NF1 gene mutation because of his presentation with multiple JXGs and moderate macrocephaly (2.5 standard deviations) at 9 months of age and JMML diagnosed at 20 months of age. The child is well today after treatment with chemotherapy and allogenic bone marrow transplantation. With increased awareness, patients with JXG and NF1 who develop symptoms possibly related to JMML, such as paleness, skin bleeding, cough, unexplained fever, and hepatosplenomegaly, should be further evaluated. We also emphasize that multiple JXG lesions can be an early marker of NF1. 相似文献
2.
3.
4.
Clinical usefulness of intraductal ultrasonography for the management of acute biliary pancreatitis
下载免费PDF全文
![点击此处可从《Journal of gastroenterology and hepatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
5.
6.
7.
K.-C. Sung D.-C. Seo S.-J. Lee M.-Y. Lee S.H. Wild C.D. Byrne 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2019,29(5):489-495
Background and aims
It is not known whether non alcoholic fatty liver disease (NAFLD) is a risk factor for diabetes in non obese, non centrally-obese subjects. Our aim was to investigate relationships between fatty liver, insulin resistance and a biomarker score for liver fibrosis with incident diabetes at follow up, in subjects who were neither obese nor centrally-obese.Methods and results
As many as 70,303 subjects with a body mass index (BMI) < 25 kg/m2 and without diabetes were followed up for a maximum of 7.9 years. At baseline, fatty liver was identified by liver ultrasound, insulin resistance (IR) by homeostatic model assessment of insulin resistance (HOMA-IR) ≥2.0, and central obesity by waist circumference (waist circumference ≥90 cm (men) and ≥85 cm (women). The Fibrosis-4 (FIB-4 score) was used to estimate extent of liver fibrosis. Cox proportional hazards models adjusted for confounders were used to estimate hazard ratios (aHRs) for incident diabetes. As many as 852 incident cases of diabetes occurred during follow up (median [IQR] 3.71 [2.03] years). Mean ± SD BMI was 22.8 ± 1.8 and 21.7 ± 2.0 kg/m2 in subjects with and without diabetes at follow up. In subjects without central obesity and with fatty liver, aHRs (95% CI) for incident diabetes at follow up were 2.17 (1.56, 3.03) for men, and 2.86 (1.50,5.46) for women. Similar aHRs for incident diabetes occurred with fatty liver, IR and the highest quartile of FIB-4 combined, in men; and there was a non significant trend toward increased risk in women.Conclusions
In normal weight, non-centrally obese subjects NAFLD is an independent risk factor for incident diabetes. 相似文献8.
Xiaoqing Guo Ji-Eun Seo Xilin Li Nan Mei 《Journal of toxicology and environmental health. Part B, Critical reviews》2020,23(1):27-50
ABSTRACTGenotoxic compounds may be detoxified to non-genotoxic metabolites while many pro-carcinogens require metabolic activation to exert their genotoxicity in vivo. Standard genotoxicity assays were developed and utilized for risk assessment for over 40 years. Most of these assays are conducted in metabolically incompetent rodent or human cell lines. Deficient in normal metabolism and relying on exogenous metabolic activation systems, the current in vitro genotoxicity assays often have yielded high false positive rates, which trigger unnecessary and costly in vivo studies. Metabolically active cells such as hepatocytes have been recognized as a promising cell model in predicting genotoxicity of carcinogens in vivo. In recent years, significant advances in tissue culture and biological technologies provided new opportunities for using hepatocytes in genetic toxicology. This review encompasses published studies (both in vitro and in vivo) using hepatocytes for genotoxicity assessment. Findings from both standard and newly developed genotoxicity assays are summarized. Various liver cell models used for genotoxicity assessment are described, including the potential application of advanced liver cell models such as 3D spheroids, organoids, and engineered hepatocytes. An integrated strategy, that includes the use of human-based cells with enhanced biological relevance and throughput, and applying the quantitative analysis of data, may provide an approach for future genotoxicity risk assessment. 相似文献
9.